alabnii/sciclaimeval-shared-task huggingface dataset:
Styled Table

Table 3
Factors associated with the intention to be vaccinated with the COVID-19 booster dose in Peru, July 2022.

Characteristics
Bivariate analysis*

Multiple regression**

cPR
95% CI
p
aPR
95% CI
p

Sex

Female
Ref.

Ref.

Male
1.02
0.97–1.07
0.434
1.05
1.01–1.10
0.024

Age (years)

18–29
Ref.

Ref.

30–44
0.93
0.87–0.99
0.031
0.94
0.88–1.01
0.076

45 years or older
0.89
0.81–0.97
0.011
0.89
0.81–0.98
0.018

Area of residence

Urban
Ref.

Rural
0.99
0.92–1.06
0.758

NA

Food insecurity

No
Ref.

Yes
1.00
0.96–1.05
0.869

NA

Economic insecurity

No
Ref.

Yes
1.01
0.96–1.06
0.670

NA

Have children

No
Ref.

Yes
0.92
0.87–0.98
0.006

NA

Education

College, pre-college, or university
Ref.

Primary school completed or less
0.94
0.77–1.15
0.552

NA

High school completed
1.04
0.99–1.09
0.130

University postgraduate degree complete
0.99
0.90–1.10
0.897

Employment status

Not related to health sciences
Ref.

In relation to health sciences
1.10
1.04–1.16
<0.001

NA

Not working, not studying
1.02
0.90–1.15
0.780

Depressive symptoms

No
Ref.

Ref.

Yes
1.00
0.94–1.05
0.938
1.03
0.97–1.08
0.315

Comorbidities

No
Ref.

Ref.

Yes
0.96
0.91–1.02
0.216
0.97
0.91–1.02
0.257

ESAVI

None
Ref.

Ref.

Mild-moderate
1.04
0.98–1.10
0.211
1.06
1.00–1-12
0.035

Severe
0.90
0.66–1.21
0.472
0.88
0.62–1.24
0.461

Symptomatology suspicious of COVID-19

No
Ref.

Ref.

Yes
1.01
0.94–1.09
0.756
0.98
0.91–1.05
0.528

Likelihood of acceptance of booster dose on the recommendation of family and friends

Negative influence/Indifferent
Ref.

Ref.

Positive influence
1.28
1.22–1.34
<0.001
1.08
1.04–1.12
<0.001

Likelihood of acceptance of booster dose at the recommendation of physicians and other health professionals

Negative influence/Indifferent
Ref.

Ref.

Positive influence
1.52
1.38–1.66
<0.001
1.40
1.27–1.55
<0.001

Probability of acceptance of the booster dose upon the recommendation of government health authorities (MINSA)

Negative influence/Indifferent
Ref.

Ref.

Positive influence
1.32
1.24–1.40
<0.001
1.05
0.99–1.11
0.124

Likelihood of acceptance of booster dose at the recommendation of politicians

Negative influence/Indifferent
Ref.

Positive influence
1.17
1.13–1.21
<0.001

NA

Perception of the efficacy and protective effect of the booster dose

No
Ref.

Yes
3.69
2.57–5.30
<0.001

NAa

Fear of adverse effects of the booster dose

No
Ref.

Ref.

Yes
0.91
0.87–0.96
<0.001
0.96
0.92–1.00
0.060

Notes: 95% CI 95% confidence interval cPR crude prevalence ratio aPR adjusted prevalence ratio NA not supported in the multiple regression model * Generalized linear models of the Poisson family with robust variances and log link were used. ** Generalized linear models of the Poisson family with robust variances and log link with stepwise test and forward selection ( p < 0.20) were used. a Not supported because of collinearity with the probability of acceptance of the booster dose on the recommendation of physicians and other health professionals.